Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Poly MedicureNSE:POLYMED +1.19%100 5-Year Yield-on-Cost % is 0.20 as of Aug. 30, 2026, which is 26% below its 10-year median of 0.27. GuruFocus rates NSE:POLYMED with a GF Score™ of 100/100 and a GF Value™ of ₹2,443.79 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Poly Medicure ranks worse than 95.56% on this metric.
Poly Medicure's yield on cost for the quarter that ended in Jun. 2026 was 0.20.
The historical rank and industry rank for Poly Medicure's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:POLYMED'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.09 Med: 0.27 Max: 1.86
Current: 0.2
During the past 13 years, Poly Medicure's highest Yield on Cost was 1.86. The lowest was 0.09. And the median was 0.27.
NSE:POLYMED's 5-Year Yield-on-Cost % is ranked worse than 95.56% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs NSE:POLYMED: 0.20
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Poly Medicure 5-Year Yield-on-Cost % Related Terms
NSE:POLYMED vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Poly Medicure's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poly Medicure 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Poly Medicure's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Poly Medicure is calculated as
Poly Medicure (NSE:POLYMED) has a 5-Year Yield-on-Cost % of 0.20 as of Aug. 30, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Poly Medicure and its competitors. This is 26% below median its historical median of 0.27. Over the past decade, Poly Medicure's 5-Year Yield-on-Cost % has ranged from 0.09 to 1.86. According to the industry distribution chart, Poly Medicure ranks #301 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 95.6%.
Is Poly Medicure's 5-Year Yield-on-Cost % too high?
Poly Medicure's current 5-Year Yield-on-Cost % of 0.20 is 26% below median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 1.86. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.43. Poly Medicure's value of 0.20 is 91.8% below this industry median. Based on the distribution chart, Poly Medicure ranks #301 out of 315 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Poly Medicure has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Poly Medicure ranks #301 out of 315 companies for 5-Year Yield-on-Cost %. This places Poly Medicure in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.43. Poly Medicure's value of 0.20 is 91.8% below this benchmark. Historically, Poly Medicure's own 5-Year Yield-on-Cost % has ranged from 0.09 to 1.86 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 2.43, Poly Medicure has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.43, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Poly Medicure's current 5-Year Yield-on-Cost % of 0.20 is 91.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Poly Medicure and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poly Medicure's current 5-Year Yield-on-Cost % is 0.20, which is 26% below median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,443.79, compared to a current price of ₹1,733.00 — trading 29.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.20, which is 26% below median its 10-year median of 0.27 and 91.8% below the Medical Devices & Instruments industry median of 2.43. Poly Medicure's overall GF Score™ is 100/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current 5-Year Yield-on-Cost % is 0.20 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?
Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued.
The current stock price of ₹1,733.00 is trading 29.1% below its estimated GF Value™ of ₹2,443.79.
GuruFocus considers Poly Medicure to be Modestly Undervalued.
Key valuation signals for NSE:POLYMED:
5-Year Yield-on-Cost %: 0.20 (26% below median its 10-year median of 0.27)
GF Value™: ₹2,443.79 vs. price of ₹1,733.00 (29.1% below fair value)
Industry Position: 91.8% below the Medical Devices & Instruments median (#301 of 315)
No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
100GF Score
Get the complete analysis for NSE:POLYMED
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:POLYMED has been successfully added to your 
